Oncology Letters · 2013 · 27 citations · 24 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologyTumor MicroenvironmentCancer BiomarkersCancer Molecular PathologyColorectal CancerMolecular Tumor ProfilingTumor MarkersColorectal Cancer PrognosisColorectal Carcinogenesis PathophysiologyCyclooxygenase IsoformsCyclooxygenase-2 PathwayGastrointestinal MucosaProtein Expression LevelsRecurrenceWestern Blotting
The development of colorectal cancer (CRC) is commonly accompanied by the overexpression of the cyclooxygenase-2 (COX-2) gene, with high levels being most common in early colorectal lesions. In the present study, we hypothesized that the expression of COX-2 in normal mucosa affects the expression of COX-2 in adjacent tumors. COX-2 protein expression levels were determined in tumor tissues and the adjacent normal mucosa of 49 paired clinical CRC specimens using western blotting and immunohistochemistry (IHC) staining. The majority of specimens exhibited an extremely low level of COX-2 expression in the tumor tissue and a markedly higher expression level in the adjacent normal tissue, however, high COX-2 expression in the tumor was shown to correlate with a high recurrence rate and poor overall survival. Of the nine CRC cell lines, HT29 showed consistently higher levels of COX-2 expression. Therefore, COX-2 expression in the normal tissue adjacent to the tumor may be involved in the tumorigenesis of CRC. These observations are likely to be useful in determining the significance of COX-2 expression in the tumorigenesis of CRC.
24
Genetic Alterations during Colorectal-Tumor Development
Bert Vogelstein, Eric R. Fearon, Stanley R. Hamilton et al. · New England Journal of Medicine · 1988 · 6.8K citations
Lipid mediator class switching during acute inflammation: signals in resolution
Bruce D. Levy, Clary B. Clish, Birgitta Schmidt et al. · Nature Immunology · 2001 · 1.4K citations
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Hajime Sano, Yutaka Kawahito, Ronald L. Wilder et al. · PubMed · 1995 · 1.1K citations
Medicine, Oncology, Pharmacology +10
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Pasha Sarraf, Elisabetta Mueller, Daniel M. Jones et al. · Nature Medicine · 1998 · 973 citations